These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 27665938)

  • 1. Center-based patient care enhances survival of elderly patients suffering from peripheral arterial disease.
    Höbaus C; Herz CT; Obendorf F; Howanietz MT; Wrba T; Koppensteiner R; Schernthaner GH
    Ann Med; 2017 Jun; 49(4):291-298. PubMed ID: 27665938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes.
    Mueller T; Hinterreiter F; Luft C; Poelz W; Haltmayer M; Dieplinger B
    J Vasc Surg; 2014 May; 59(5):1291-9. PubMed ID: 24393280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease.
    Mueller T; Hinterreiter F; Poelz W; Haltmayer M; Dieplinger B
    Vasc Med; 2016 Oct; 21(5):445-452. PubMed ID: 27067137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in patients with premature lower extremity atherosclerosis.
    Rana H; Andrews JS; Chacko BG; Hansen KJ; Levy PJ
    J Vasc Surg; 2013 Jan; 57(1):28-35; discussion 35-6. PubMed ID: 23146425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein as predictor of death in end-stage diabetic nephropathy: role of peripheral arterial disease.
    Böger CA; Götz A; Stubanus M; Banas B; Deinzer M; Krüger B; Holmer SR; Schmitz G; Riegger GA; Krämer BK
    Kidney Int; 2005 Jul; 68(1):217-27. PubMed ID: 15954911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy-associated plasma protein-A as a marker for long-term mortality in patients with peripheral atherosclerosis: inconclusive findings from the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T; Dieplinger B; Forstner T; Poelz W; Haltmayer M
    Clin Chem Lab Med; 2010 Apr; 48(4):537-42. PubMed ID: 20148724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease.
    Feringa HH; van Waning VH; Bax JJ; Elhendy A; Boersma E; Schouten O; Galal W; Vidakovic RV; Tangelder MJ; Poldermans D
    J Am Coll Cardiol; 2006 Mar; 47(6):1182-7. PubMed ID: 16545650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in peripheral arterial disease: a comparison of patients managed by vascular specialists and general practitioners.
    Brevetti G; Oliva G; Giugliano G; Schiano V; De Maio JI; Chiariello M
    J Gen Intern Med; 2007 May; 22(5):639-44. PubMed ID: 17354043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) study.
    Dieplinger B; Haltmayer M; Poelz W; Mueller T
    Clin Chim Acta; 2009 Oct; 408(1-2):87-91. PubMed ID: 19646980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial.
    Depalma RG; Hayes VW; Chow BK; Shamayeva G; May PE; Zacharski LR
    J Vasc Surg; 2010 Jun; 51(6):1498-503. PubMed ID: 20304584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple biomarkers for mortality prediction in peripheral arterial disease.
    Amrock SM; Weitzman M
    Vasc Med; 2016 Apr; 21(2):105-12. PubMed ID: 26762418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease.
    Diehm C; Allenberg JR; Pittrow D; Mahn M; Tepohl G; Haberl RL; Darius H; Burghaus I; Trampisch HJ;
    Circulation; 2009 Nov; 120(21):2053-61. PubMed ID: 19901192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
    Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
    J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein.
    Owens CD; Kim JM; Hevelone ND; Hamdan A; Raffetto JD; Creager MA; Conte MS
    J Vasc Surg; 2010 May; 51(5):1152-9. PubMed ID: 20223619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality--the CAVASIC Study.
    Pohlhammer J; Kronenberg F; Rantner B; Stadler M; Peric S; Hammerer-Lercher A; Klein-Weigel P; Fraedrich G; Kollerits B
    Atherosclerosis; 2014 Dec; 237(2):711-7. PubMed ID: 25463110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention.
    Pereg D; Elis A; Neuman Y; Mosseri M; Segev D; Granek-Catarivas M; Lishner M; Hermoni D
    Coron Artery Dis; 2014 Jan; 25(1):79-82. PubMed ID: 24128887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral arterial disease is associated with an increased risk of atrial fibrillation in the elderly.
    Griffin WF; Salahuddin T; O'Neal WT; Soliman EZ
    Europace; 2016 Jun; 18(6):794-8. PubMed ID: 26589625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease.
    Urbonaviciene G; Martin-Ventura JL; Lindholt JS; Urbonavicius S; Moreno JA; Egido J; Blanco-Colio LM
    Atherosclerosis; 2011 Dec; 219(2):892-9. PubMed ID: 21962403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.